Jeremy Bender, Chief Executive Officer at Day One Biopharmaceuticals, Inc. (DAWN), sold 12,500 shares at $20.03 ($250K) on 2022-11-01, disclosed to the SEC on 2022-11-03.
Open-market sale of $250k DAWN by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| DAWN | SELL | 2025-08-19 | $217K | — | Filing → |
| DAWN | SELL | 2025-05-19 | $175K | — | Filing → |
| DAWN | SELL | 2025-02-21 | $288K | — | Filing → |